6p5m: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "6p5m" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 6p5m is ON HOLD | The entry 6p5m is ON HOLD until Paper Publication | ||
Authors: Hoffman, I.D., Skene, R.J. | Authors: Hoffman, I.D., Skene, R.J. | ||
Revision as of 08:54, 17 July 2019
Unreleased structure
The entry 6p5m is ON HOLD until Paper Publication
Authors: Hoffman, I.D., Skene, R.J.
Description: Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent
